FY2026 EPS Estimates for Transcat Increased by HC Wainwright

Key Points

• HC Wainwright has raised its earnings per share (EPS) estimate for Transcat for FY2026 to $2.25, up from $1.87, maintaining a "Buy" rating with a target price of $116.00.
• Transcat reported a quarterly EPS of $0.59, exceeding the consensus estimate of $0.40, with revenues reaching $76.42 million.
• The company's stock has a consensus rating of "Moderate Buy" and a price target of $112.20, with significant institutional ownership at 98.34%.

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Equities research analysts at HC Wainwright boosted their FY2026 earnings estimates for shares of Transcat in a report issued on Monday, August 11th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will earn $2.25 per share for the year, up from their previous estimate of $1.87. HC Wainwright has a "Buy" rating and a $116.00 price target on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q4 2026 earnings at $0.76 EPS.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.19. The company had revenue of $76.42 million during the quarter, compared to the consensus estimate of $72.28 million. Transcat had a net margin of 4.64% and a return on equity of 6.66%.

Several other research analysts also recently weighed in on the stock. Lake Street Capital began coverage on shares of Transcat in a report on Thursday, July 10th. They issued a "buy" rating and a $105.00 target price for the company. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Transcat currently has a consensus rating of "Moderate Buy" and a consensus price target of $112.20.

Transcat Price Performance

Transcat stock traded up $0.07 during mid-day trading on Wednesday, hitting $81.54. The stock had a trading volume of 54,826 shares, compared to its average volume of 82,974. The firm has a market capitalization of $759.95 million, a P/E ratio of 57.02 and a beta of 0.71. The company has a current ratio of 2.92, a quick ratio of 2.36 and a debt-to-equity ratio of 0.11. The firm's 50 day moving average is $81.95 and its 200 day moving average is $80.41. Transcat has a one year low of $67.56 and a one year high of $133.72.

Institutional Trading of Transcat

Hedge funds have recently bought and sold shares of the stock. Lazard Asset Management LLC purchased a new stake in Transcat in the 2nd quarter worth $54,000. Quantbot Technologies LP purchased a new stake in shares of Transcat during the 1st quarter valued at about $76,000. Parkside Financial Bank & Trust purchased a new stake in shares of Transcat during the 2nd quarter valued at about $79,000. PNC Financial Services Group Inc. raised its position in shares of Transcat by 1,118.2% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company's stock valued at $92,000 after buying an additional 984 shares in the last quarter. Finally, State of Wyoming purchased a new stake in shares of Transcat during the 1st quarter valued at about $95,000. Hedge funds and other institutional investors own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.